
At Blackrock Neurotech, we’ve spent decades making the impossible possible – helping people move, speak, and reconnect with the world when they otherwise could not. We’ve seen that restoring function restores more than ability. It restores independence, identity, and agency.
Today, we are building the next generation of human capability: brain-computer interfaces that are designed to be safe, scalable, and trusted in the real world. Our work is not only about reconnecting people to what was lost, but about expanding what is possible – creating a seamless interface between human intent and technology.
This is foundational work in a category-defining field. You will help build the infrastructure for a future where neural interfaces are invisible, reliable, and deeply human-centered.
The Vice President, Regulatory Affairs & Quality Assurance will provide strategic and operational leadership across Blackrock Neurotech’s Regulatory Affairs and Quality Assurance functions. You will guide the regulatory strategy and quality systems that support the development, clinical advancement, regulatory approval, and commercialization of next-generation neurotechnology and implantable brain-computer interface products.
You will establish an integrated regulatory and quality strategy aligned with the company’s product development and business objectives, maintain a robust, scalable Quality Management System, and ensure compliance with applicable global requirements. You will provide executive oversight of Clinical Affairs, partnering with the Director to align clinical evidence and study milestones with regulatory requirements and product objectives.
As a member of the leadership team, you will partner closely with the CEO and leaders across R&D, Engineering, Clinical Affairs, Operations, and Commercial to assess current capabilities, establish clear priorities, and build the people, processes, and systems required to advance clinical milestones and support long-term commercialization.
You will operate with meaningful ownership in a high-consequence environment, contributing to systems that must be precise, reliable, and durable.
We are a small, experienced team working on consequential problems.
This is a high-ownership role, but it is not an "always-on" one. We expect strong work and our people to have a life outside of it.
Making Salt Lake City, UT your home base is ideal, however, we will consider remote work for this position. We ask that remote employees commit to regular on-site visits for routine work and departmental events.

Blackrock Neurotech is a team of the world’s leading engineers, neuroscientists, and visionaries. Our mission is simple: We want people with neurological disorders to walk, talk, see, hear, and feel again. We’re engineering the next generation of neural implants, including implantable brain-computer interface technology that restores function and independence to individuals with neurological disorders. Join us in changing lives today.
Connect with us:
Join Our Team | https://bit.ly/3bCsXRv
LinkedIn | https://bit.ly/3PfifOL
Twitter | https://bit.ly/3PfifOL
Instagram | https://bit.ly/3bMaYrW
Facebook | https://bit.ly/3JRc2av
Clinical Trials | https://bit.ly/3A8QPWm
Our site | https://blackrockneurotech.com
Additional information:
As the world leader in BCI tech, our pioneering neuroscience tools push the boundaries of research and empower innovation across more than 500+ global institutional partners, restoring function in patients suffering from neurological disease (ALS, Alzheimer’s, Parkinson’s), dysfunction (epilepsy, pain, brain trauma), and paralysis disorders. Our systems can be optimized from the ground up to handle even the most challenging applications.
Our BCI is the most sophisticated and long-tested human BCI, interfacing with the brain and empowering independence in those with paralysis & other neurological disorders since 2004. In fact, dozens of patients have used our BCI for a collective 30,000+ days to regain freedom through movement and communication. Our first commercial BCI, MoveAgain, received a Breakthrough Designation from the FDA in 2021 and is expected to be commercially available in 2023.
Join us in changing lives today.